PTC Therapeutics (PTCT) - News Mentions

Sign up to add (PTCT) to your portfolio and access more historical data.

10%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 0%
Gilead Sciences
Gilead Sciences
GILD		 2 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 100%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Bought by State of New Jersey Common Pension Fund D
November 15
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
November 14
PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
November 13
PTC Therapeutics Third Quarter 2024 Earnings: Beats Expectations
November 8
PTC Therapeutics Inc (PTCT) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
November 7
PTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
November 7
PTC Therapeutics, Inc. (PTCT) Q3 2024 Earnings Call Transcript
November 7
PTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue Estimates
November 7
PTC Therapeutics: Q3 Earnings Snapshot
November 7
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
November 7
Unlocking Q3 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics
November 5
Mirae Asset Global Investments Co. Ltd. Buys 492 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT)
November 5
PTC Therapeutics to Participate at Upcoming Investor Conferences
November 4
PTC Therapeutics (NASDAQ:PTCT) Sets New 1-Year High - Time to Buy?
October 30
PTC Therapeutics (NASDAQ:PTCT) grows 8.1% this week, taking one-year gains to 127%
October 29
PTC Therapeutics Announces FDA Acceptance of Translarna™ NDA Resubmission
October 29

Month over Month

Est. daily news mentions.

Oct 2024 1
Sep 2024 0
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is PTC Therapeutics mentioned in the news?

PTC Therapeutics was mentioned an estimated 1 times in online prominent news articles yesterday.

Analyzing News Mentions, how is PTC Therapeutics performing compared to its industry peers?

PTC Therapeutics underperforms its industry peers when it comes to News Mentions, ranking in the 20th percentile.

Has there been an increase or decrease in news mentions of PTC Therapeutics in the last month?

There has been no significant change in the number of news mentions for PTC Therapeutics' compared to the last month.

Why is it important to track news mentions for PTC Therapeutics?

By monitoring mentions in the news for PTC Therapeutics, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of PTC Therapeutics, ultimately improving their investment strategies.

Sign up and get more insights on PTC Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact